Arvid Söderhäll

Arvid Söderhäll

Company: Empros Pharma

Job title: Chief Executive Officer


How Sustainable is Drug-Based Management of Chronic Obesity & When Should Treatment Start? 11:45 am

Finite treatment beyond GLP-1 receptor agonists: establishing sustainable treatment of obesity Advancing a safer and more potent method to address the medical need of obese patients in combination with other treatments Navigating early intervention: when does it make sense to start treating patients?Read more

day: Day 2 Stream 2 AM

Panel Discussion: Obesity, Diabetes & NASH: What do Payers Need to See? 2:00 pm

Defining payer expectations and considering long term value Assessing higher risk patient populations and preventing comorbidities Harmonizing global patient metricsRead more

day: Day 1 Stream 2 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.